Company News Summary
Starpharma Holdings Signs DEP Research Agreement with Genentech
07 Dec 2021 | 09:16:00 | Associate analysts | Increase | Decrease | 
Original announcement: Starpharma signs DEP Research Agreement with US Biopharma Co
Starpharma Holdings announced that it has signed an exploratory DEP Research Agreement with Genentech, a member of the Roche Group, with an initial focus on evaluating DEP (dendrimer based) drug conjugates. It also has a number of existing DEP partnerships with international pharmaceutical companies, including AstraZeneca, Merck & Co, Chase Sun, as well as several undisclosed partnerships.
See more ASX300 News Announcements